ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Brian Buxton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buxton, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Buxton, B.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2003;75:1152
© 2003 The Society of Thoracic Surgeons

Invited commentary

Brian Buxton, MD

Director of Cardiac Surgery, Austin and Repatriation Medical Centre, Level 5, Studley Road, Heidelberg, Victoria 3084, Australia

e-mail: brian.buxton@armc.org.au

The first 20% of the full text of this article appears below.

Meticulous harvesting, pharmacologic dilatation, and avoidance of overdistention of a coronary artery bypass graft have been recognized as important steps during procurement, which may preserve graft function. Nonetheless, some vein grafts develop early complications such as thrombosis and neointimal hyperplasia which lead to atherosclerosis. Preservation during storage of a coronary artery graft between the time of harvest and implantation has received little attention, possibly because conduits are thought by many surgeons to be inert or robust and . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.